Home›Stock Screener›Anuh Pharma›Quarterly Results

Anuh Pharma Quarterly Results for Trading Insights

Latest Quarter Net Profit
₹39 Cr
QMarch 2026
Quarterly Results

In March 2026, Anuh Pharma (ANUHPHR) reported revenue ₹772 Cr and net profit ₹39 Cr — revenue +15.1% YoY. Compare with Anuh Pharma value estimation to assess whether the stock is under or overvalued.

ANUHPHR Quarterly Results — Revenue, Profit & EPS Highlights

Anuh Pharma latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. For annual financials, live price and key ratios, visit ANUHPHR screener.

  • Revenue of ₹772 Cr in March 2026 (+15.1% vs March 2025, +15.1% vs March 2025)
  • Net Profit of ₹39 Cr in March 2026 (-17.0% vs March 2025, -17.0% vs March 2025)
  • EBITDA of ₹62 Cr in March 2026 (-11.4% vs March 2025)
  • Operating Margin of 8.0% in March 2026 (-1.0pp vs March 2025)
  • Earnings Per Share of ₹4.10 in March 2026 (-56.6% vs March 2025)

Anuh Pharma Quarterly Results — Revenue, EBITDA, Net Profit & EPS

ANUHPHR quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric March 2026 March 2025 March 2024 March 2023 March 2022 QoQ YoY
Revenue (₹ Cr) 772 671 659 534 492 15.1% 15.1%
Net Profit (₹ Cr) 39 47 60 36 31 - -
EBITDA (₹ Cr) 62 70 87 57 52 - -
EPS (₹) 4.10 9.45 11.98 7.22 6.10 - -
Operating Margin (%) 8.0% 9.0% 12.0% 10.0% 10.0% - -

ANUHPHR Share Price Trend — 1-Year Movement Across Quarterly Results

Anuh Pharma 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Also explore ANUHPHR price movement history to track price trends across different timeframes.

Profitability Ratios

Profit Margin 5.1%
EBITDA Margin 8.0%
Operating Margin 8.0%
ROE (Annual) 11.1%

Balance Sheet Highlights

Total Assets ₹557 Cr
Total Equity ₹352 Cr
Current Assets ₹451 Cr
Current Liabilities ₹2 Cr

Cash Flow Analysis

Operating Cash Flow ₹37 Cr
Investing Cash Flow ₹-20 Cr
Financing Cash Flow ₹-5 Cr
Net Cash Flow ₹12 Cr

Current Market Data

Current Price ₹75.58
Exchange NSE
Last Updated May 22, 2026

Revenue Trend (₹ Cr)

March 2023 534
March 2024 659
March 2025 671
March 2026 772

Net Profit Trend (₹ Cr)

March 2023 36
March 2024 60
March 2025 47
March 2026 39

Operating Margin Trend (%)

March 2023 10.0%
March 2024 12.0%
March 2025 9.0%
March 2026 8.0%

ANUHPHR vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Anuh Pharma latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹450,643.09 Cr 1844.6 14,875 3,125 +10.8% - 21.0% 141.9
Divis Laboratories
Sept 2025 		₹179,470.03 Cr 6887.0 2,860 689 +7.1% - 24.1% 265.2
Torrent Pharmaceuti…
Mar 2026 		₹151,833.39 Cr 4486.2 4,111 364 +27.7% +42.2% 8.9% 389.8
Cipla
Mar 2026 		₹113,024.67 Cr 1399.2 6,612 543 -14.3% -4.0% 8.2% 203.7
Dr Reddys Laborator…
Mar 2026 		₹109,104.54 Cr 1307.2 7,996 221 -12.5% -11.5% 2.8% 493.3
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores